Edesa Biotech (EDSA) Misses Q2 EPS by 6c
Edesa Biotech (NASDAQ: EDSA) reported Q2 EPS of ($0.52), $0.06 worse than the analyst estimate of ($0.46).
For earnings history and earnings-related data on Edesa Biotech (EDSA) click here.
Edesa Biotech (NASDAQ: EDSA) reported Q2 EPS of ($0.52), $0.06 worse than the analyst estimate of ($0.46).
For earnings history and earnings-related data on Edesa Biotech (EDSA) click here.